Erectile Dysfunction Meds Linked To 85% Higher Serious Eye Damage Risk, Study Says
Regular use of ED medications such as sildenafil (e.g., Viagra), vardenafil (e.g., Levitra and Staxyn), tadalafil (Cialis), and avanafil (Stendra) was associated with increased risk of three serious eye problems. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 9, 2022 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news

Erectile Dysfunction Meds Like Viagra, Cialis: 85% Increase In Serious Vision Problems, Study Says
Regular use of ED medications such as sildenafil (e.g., Viagra), vardenafil (e.g., Levitra and Staxyn), tadalafil (Cialis), and avanafil (Stendra) was associated with increased risk of three serious eye problems. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 9, 2022 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news

Viagra users are 85% more likely to develop eye conditions, study finds
University of British Columbia researchers found the erectile dysfunction medication can increase the risk of vision problems. Cialis, Levitra and Spedra were also linked. (Source: the Mail online | Health)
Source: the Mail online | Health - April 7, 2022 Category: Consumer Health News Source Type: news

New Jersey Husband and Wife Admit Selling Misbranded and Unapproved New Drugs
FDA OCI, Sylvia Kovaleski, South Amboy NJ, Keith Kovaleski, All American Peptide, AAP, market, distribute, bodybuilders, weight training, enhance, performance, mitigate, side effects, prescription drugs, Rx, tadalafil, Cialis, SARMs, peptides, clenbuterol, basement, manufacturing facility, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - March 24, 2022 Category: Medical Law Authors: DOJ Source Type: news

Sioux City Man Sentenced for Selling Misbranded Erectile Dysfunction Drugs as Dietary Supplements “All-Natural Male” and “Supermale”
FDA OCI, David Kempema, Sioux City IA, sentence, misbranded, Rx, drug, ED, erectile dysfunction, dietary supplements, All-Natural Male, Supermale, prison, India, Germany, Viagra, Cialis, 2011, conviction, drug trafficking, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - March 22, 2022 Category: Medical Law Authors: DOJ Source Type: news

Eli Lilly to halt exports of non-essential medicines to Russia
Erectile dysfunction drug Cialis among treatments that will no longer be provided (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - March 15, 2022 Category: Pharmaceuticals Source Type: news

Positive-Health Issues Voluntary Nationwide Recall of RISE UP RED EDITION Capsules Due to the Presence of Undeclared Tadalafil
Wilmington DE, Positive-Health is voluntarily recalling lot number 48658908 with Expiry 9/9/23 of Rise Up Red Edition Capsules packaged in 10-count blisters packaged in a carton to the consumer level. Positive-Health was notified by Amazon that laboratory analysis has found the product to be tainted (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 10, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Celebrate Today Issues Voluntary Nationwide Recall of One Lot of Red Mammoth Due to the Presence of Undeclared Sildenafil and Tadalafil
Brentwood, NY, Celebrate Today is voluntarily recalling lot number DK1027, Exp 08/01/2023 of Red Mammoth capsules to the consumer level. Celebrate Today was informed by Amazon that laboratory analysis has found the product to be tainted with sildenafil and tadalafil, an ingredients known as a phosph (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 9, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

ABC SALES 1 INC Issues Voluntary Nationwide Recall of MAC DADDY RED and MAC DADDY PURPLE Capsules Due to the Presence of Undeclared Sildenafil and Tadalafil
ABC SALES 1 INC is voluntarily recalling MAC DADDY RED Capsules, Lot 1230004, Exp 03/30/2024 and MAC DADDY PURPLE Capsules, Lot 1230005, Exp 03/30/2024 to the consumer level. ABC Sales 1 Inc was informed by Amazon that laboratory analysis found MAC DADDY RED capsules to be tainted with sildenafil an (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 8, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Your Favorite Shop Issues Voluntary Nationwide Recall of the Red Pill Capsules, Due to the Presence of Undeclared Tadalafil
Your Favorite Shop is voluntarily recalling lot # 26436989. Expiry 10/30/2023 of The Red Pill, packaged in 10-count blisters packaged in a carton to the consumer level. Your Favorite Shop was notified by Amazon that laboratory analysis has found the product to be tainted with tadalafil, an ingredien (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 8, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Junp LLC Issues Voluntary Nationwide Recall of MegMan Performance Booster Capsules Due to the Presence of Tadalafil
Brooklyn, NY Junp LLC is voluntarily recalling Lot number 2010291, Exp Date: 01/07/2024 of MegMan Performance Booster capsules, packaged in 10-count blisters packaged in a carton to the consumer level. Junp LLC was notified by Amazon that laboratory analysis has found the product to be tainted wit (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 4, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Esupplementsales, LLC Issues a Nationwide Recall of One Lot of Hard Dawn Due to the Presence of Undeclared Tadalafil
Orangevale, CA, Esupplementsales, LLC is voluntarily recalling lot number 2107 of Hard Dawn Rise and Shine capsules to the consumer level. Esupplementsales, LLC was informed by Amazon that laboratory analysis has found the product to be tainted with tadalafil, an ingredient known as a phosphodieste (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 2, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Esupplementsales, LLC Issues a Nationwide Recall All Lots of Hard Dawn Due to the Presence of Undeclared Tadalafil
Orangevale, CA, Esupplementsales, LLC is voluntarily recalling lot number 2107 of Hard Dawn Rise and Shine capsules to the consumer level. Esupplementsales, LLC was informed by Amazon that laboratory analysis has found the product to be tainted with tadalafil, an ingredient known as a phosphodieste (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - January 31, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA Approves Entadfi (finasteride and tadalafil) as a New Treatment for Benign Prostatic Hyperplasia
MIAMI, Dec. 13, 2021 (GLOBE NEWSWIRE)— Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of breast and prostate cancer, announced today that the U.S. Food and Drug... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 13, 2021 Category: Drugs & Pharmacology Source Type: news

Erectile Dysfunction Drug Tadalafil Exerts Modest Glucose Control Erectile Dysfunction Drug Tadalafil Exerts Modest Glucose Control
In men with erectile dysfunction and type 2 diabetes, a prospective, placebo-controlled study showed that the erectile dysfunction agent tadalafil produced modest but significant glucose control.First Look (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - December 9, 2021 Category: Primary Care Tags: Urology News Source Type: news